& Bernet, V
FAQs About GLP-1 and GIP/GLP-1s for Obesity 9 Although GLP-1 medications have been used for type 2 diabetes since 2005 (in lower doses than what is prescribed now for weight loss), its still too early to know the long-term effects of using them specifically for obesity
So, contrary to the popular no pain, no gain dogma, take care to practice healthy fitness and discover the balance that currently works for you, including adequate rest and recovery
For example, PEG-lipid modified exenatide-loaded nanoparticles have been studied for their ability to cross mucosal barriers and improve oral bioavailability [34]
I dont think its anyones business. Dubrow compares the use of Ozempic and Wegovy to the early days of Botox (which she automatically embraced, being married to a plastic surgeon)
For licensed medicines, suspected side effects can also be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk